login
Password reminder
Interventional News
Contact the editor Visit Interventional News Twitter feed Visit Interventional News Facebook page
 

Avinger’s Ocelot catheter is CE marked


Thursday, 29 Sep 2011 11:21

Avinger has received CE mark approval for Ocelot ― a peripheral catheter system used with real-time Optical Coherence Tomography (OCT) for the treatment of peripheral artery disease.


According to Avinger, medical professionals, for the first time ever, will have access to a therapeutic device that incorporates real time intravascular guidance by using Ocelot’s Lightbox console as an adjunct to fluoroscopy.


“Ocelot CE mark is a long anticipated milestone for Avinger and a much larger milestone for me professionally. I have been working on uniting intravascular guidance with therapeutic products for 30 years and I am humbled that we have been able to achieve this at Avinger,” said John B Simpson, Avinger’s founder and CEO.


Avinger is currently enrolling patients in the VISTA study ― a single-centre, non-randomised registry designed to evaluate the safety and efficacy of Ocelot in patients with peripheral artery disease. The registry is being developed in Paraguay, with Adrian Ebner of Sanitorio Italiano in Asunción, as the principal investigator.


European comercialisation of Ocelot has already begun. The first three commercial cases are scheduled to be performed in Italy and Germany in late September and early October.

 




Add New Comment

Most popular


Philips and Academic Medical Center aim to improve care for diabetic patients with severe foot complications
Thursday, 28 May 2015
The European study in which Philips and AMC are collaborating will start in the summer of 2015 with final results expected in 2017. Philips and Academic Medical Center aim to improve care for diabetic patients with severe foot complications

FDA grants premarket approval for Enroute transcarotid stent system
Tuesday, 19 May 2015
The Enroute transcarotid stent (Silk Road Medical) is the first carotid stent that is introduced and implanted into the carotid artery through a direct common carotid access point to enable a safe ... FDA grants premarket approval for Enroute transcarotid stent system

Companies announce new round of renal denervation randomised trials
Monday, 08 Jun 2015
Medtronic has announced the initiation of the SPYRAL HTN clinical trial programme studying renal denervation in uncontrolled hypertension, and Boston Scientific has announced the initiation of the RED... Companies announce new round of renal denervation randomised trials

Features


Aneurysm Coiling Efficiency (ACE) registry shows positive results for Ruby coil peripheral vasculature
Wednesday, 10 Jun 2015
The Aneurysm Coiling Efficiency registry offers an opportunity to study the demographics and long-term outcomes of a cohort of patients with embolization of the peripheral vasculature using Ruby ... Aneurysm Coiling Efficiency (ACE) registry shows positive results for Ruby coil peripheral vasculature

Interventional radiology solutions for hydatic disease
Wednesday, 10 Jun 2015
Hydatid disease (cystic Echinococcus) caused by Echinococcus granulosus is an endemic disease and a significant public health problem in many parts of the world. Interventional radiology solutions for hydatic disease

Profiles


Lindsay Machan
Thursday, 28 May 2015
“Focussing on maximising rewards has sidelined more ideas than it has helped individual inventors. S... Lindsay Machan

Gao-Jun Teng
Thursday, 11 Dec 2014
In the future, will interventional radiology be a subspecialty of radiology, or surgery? asks Gao-J... Gao-Jun Teng

Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions